Navigation Links
Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
Date:3/10/2010

SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Roth 22nd Annual OC Growth Conference in Laguna Niguel.

The live presentation takes place Tuesday, March 16, 2010 at 12:30 p.m. Eastern Time (ET)/9:30 a.m. Pacific Time (PT).  The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.

Back to top

RELATED LINKS
http://www.neurocrine.com

'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors
2. Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain
3. Neurocrine Biosciences Amends Corporate Headquarters Lease
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences Secures Committed Equity Financing Facility
6. Neurocrine Biosciences Reports Second Quarter 2009 Results
7. Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results
9. Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
10. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
11. Neurocrine Biosciences Reports First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2017)... DC (PRWEB) , ... September 14, 2017 , ... AIM ... IT, Medical Tracking Systems Inc. has won the 2017 Case Study Competition for AIDC. ... technologies which provide benefits that decrease risk” and push the adoption of automated data ...
(Date:9/12/2017)... ... September 12, 2017 , ... PhysIQ, a Chicago-based company ... ambulatory patient monitoring and clinical trial support, earned DPharm Idol 2017 honors at ... , Launched in 2005, PhysIQ leverages artificial intelligence (AI) to empower digital ...
(Date:9/12/2017)... MARYLAND (PRWEB) , ... September 12, 2017 , ... ... Board for 2017-2018 are asked to submit a "pre-proposal” by October 15, ... the opportunity to greenlight projects that are aligned with our priorities, and to ...
(Date:9/12/2017)... & Cambridge (PRWEB) , ... September 11, 2017 ... ... with US offices in Cambridge, MA, announce today that Holotype HLA and other ... at the annual meeting of the American Society for Histocompatibility and Immunogenetics ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):